KNOTUS Co.Ltd (278650) - Net Assets

Latest as of September 2025: ₩112.17 Billion KRW ≈ $76.02 Million USD

Based on the latest financial reports, KNOTUS Co.Ltd (278650) has net assets worth ₩112.17 Billion KRW (≈ $76.02 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩156.41 Billion ≈ $106.00 Million USD) and total liabilities (₩44.24 Billion ≈ $29.98 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 278650 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩112.17 Billion
% of Total Assets 71.72%
Annual Growth Rate 38.31%
5-Year Change 108.55%
10-Year Change N/A
Growth Volatility 34.06

KNOTUS Co.Ltd - Net Assets Trend (2016–2024)

This chart illustrates how KNOTUS Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 278650 asset base for the complete picture of this company's asset base.

Annual Net Assets for KNOTUS Co.Ltd (2016–2024)

The table below shows the annual net assets of KNOTUS Co.Ltd from 2016 to 2024. For live valuation and market cap data, see KNOTUS Co.Ltd (278650) total market value.

Year Net Assets Change
2024-12-31 ₩111.87 Billion
≈ $75.82 Million
+8.01%
2023-12-31 ₩103.57 Billion
≈ $70.19 Million
+47.38%
2022-12-31 ₩70.28 Billion
≈ $47.63 Million
+8.81%
2021-12-31 ₩64.59 Billion
≈ $43.77 Million
+20.40%
2020-12-31 ₩53.64 Billion
≈ $36.35 Million
+28.14%
2019-12-31 ₩41.86 Billion
≈ $28.37 Million
+102.54%
2018-12-31 ₩20.67 Billion
≈ $14.01 Million
+28.84%
2017-12-31 ₩16.04 Billion
≈ $10.87 Million
+92.00%
2016-12-31 ₩8.36 Billion
≈ $5.66 Million
--

Equity Component Analysis

This analysis shows how different components contribute to KNOTUS Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 321.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩23.26 Billion 20.80%
Common Stock ₩8.67 Billion 7.75%
Other Components ₩79.94 Billion 71.45%
Total Equity ₩111.87 Billion 100.00%

KNOTUS Co.Ltd Competitors by Market Cap

The table below lists competitors of KNOTUS Co.Ltd ranked by their market capitalization.

Company Market Cap
Centrale d'Achat Française pour l'Outre-Mer Société Anonyme
PA:CAFO
$72.84 Million
YEAH1 Group Corp
VN:YEG
$72.87 Million
DCM Corp
KO:024090
$72.91 Million
SANU GOLD CORP.
F:L73
$72.91 Million
Income Opportunity Realty Investors
NYSE MKT:IOR
$72.78 Million
SEOHAN Const. & Eng.co.Ltd
KQ:011370
$72.78 Million
Miko NV
BR:MIKO
$72.78 Million
Muda Holdings Bhd
KLSE:3883
$72.76 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in KNOTUS Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 101,590,276,710 to 111,874,278,310, a change of 10,284,001,600 (10.1%).
  • Net loss of 8,564,408,980 reduced equity.
  • Share repurchases of 3,115,436,160 reduced equity.
  • New share issuances of 2,794,147,000 increased equity.
  • Other factors increased equity by 19,169,699,740.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩-8.56 Billion -7.66%
Share Repurchases ₩3.12 Billion -2.78%
Share Issuances ₩2.79 Billion +2.5%
Other Changes ₩19.17 Billion +17.14%
Total Change ₩- 10.12%

Book Value vs Market Value Analysis

This analysis compares KNOTUS Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.96x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 6.85x to 0.96x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩185.67 ₩1272.00 x
2017-12-31 ₩294.37 ₩1272.00 x
2018-12-31 ₩372.50 ₩1272.00 x
2019-12-31 ₩635.71 ₩1272.00 x
2020-12-31 ₩789.69 ₩1272.00 x
2021-12-31 ₩915.74 ₩1272.00 x
2022-12-31 ₩996.42 ₩1272.00 x
2023-12-31 ₩1265.09 ₩1272.00 x
2024-12-31 ₩1328.74 ₩1272.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently KNOTUS Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -7.66%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -14.72%
  • • Asset Turnover: 0.35x
  • • Equity Multiplier: 1.50x
  • Recent ROE (-7.66%) is below the historical average (11.53%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 29.14% 21.82% 0.57x 2.34x ₩1.60 Billion
2017 26.89% 14.70% 0.90x 2.04x ₩2.71 Billion
2018 17.20% 9.55% 0.85x 2.12x ₩1.49 Billion
2019 10.02% 9.11% 0.75x 1.47x ₩8.87 Million
2020 15.48% 14.19% 0.79x 1.38x ₩2.94 Billion
2021 17.08% 17.13% 0.68x 1.47x ₩4.57 Billion
2022 -4.26% -3.47% 0.50x 2.45x ₩-10.02 Billion
2023 -0.16% -0.31% 0.31x 1.69x ₩-10.32 Billion
2024 -7.66% -14.72% 0.35x 1.50x ₩-19.75 Billion

Industry Comparison

This section compares KNOTUS Co.Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $368,573,438,392
  • Average return on equity (ROE) among peers: 0.96%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
KNOTUS Co.Ltd (278650) ₩112.17 Billion 29.14% 0.39x $72.81 Million
ORIENTBIO Inc. (002630) $57.60 Billion 0.00% 0.70x $43.15 Million
Green Cross (005250) $1.51 Trillion 0.20% 0.84x $425.10 Million
Green Cross Holdings Preference Shares (005257) $1.85 Trillion 1.30% 0.98x $3.74 Million
Pharmicell (005690) $51.52 Billion 8.44% 0.23x $736.42 Million
GeneOne Life Science Inc (011000) $39.74 Billion 0.00% 0.49x $49.94 Million
HLB Co. Ltd (028300) $19.44 Billion 0.00% 0.66x $5.41 Billion
Daesung Microbiological Labs. Co. Ltd (036480) $37.00 Billion 2.34% 0.69x $19.29 Million
Seoulin Bioscience Co.Ltd (038070) $51.49 Billion 4.00% 0.38x $37.92 Million
Hyundai Bioscience Co. Ltd (048410) $58.24 Billion 3.27% 0.77x $872.13 Million
iNtRON Biotechnology Inc (048530) $11.93 Billion -9.93% 0.65x $77.34 Million

About KNOTUS Co.Ltd

KQ:278650 Korea Biotechnology
Market Cap
$72.81 Million
₩107.45 Billion KRW
Market Cap Rank
#20422 Global
#1188 in Korea
Share Price
₩1272.00
Change (1 day)
-1.93%
52-Week Range
₩1099.00 - ₩1683.00
All Time High
₩36886.01
About

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more